AFJKR - Aimei Health Techn... Stock Analysis | Stock Taper
Logo
Aimei Health Technology Co., Ltd

AFJKR

Aimei Health Technology Co., Ltd NASDAQ
$0.12 -13.87% (-0.02)

Market Cap $885073
52w High $0.13
52w Low $0.10
P/E 0
Volume 35.31K
Outstanding Shares 7.34M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q1-2026 $0 $61.98K $45.44K 0% $0.01 $-61.98K
Q4-2025 $0 $250.59K $98.12K 0% $0.02 $-250.59K
Q3-2025 $0 $130.15K $352.02K 0% $0.06 $-130.15K
Q2-2025 $0 $41.6K $424.97K 0% $0.07 $-41.6K
Q1-2025 $0 $413.41K $184.66K 0% $0.02 $-413.41K

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q1-2026 $18.52K $12.29M $4.21M $8.09M
Q4-2025 $2.93K $12.1M $4.06M $8.04M
Q3-2025 $2.98K $45.47M $3.46M $42M
Q2-2025 $2.14K $44.56M $2.9M $41.65M
Q1-2025 $7.34K $43.6M $2.38M $41.23M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q1-2026 $45.44K $-74.61K $-68.66K $158.86K $15.59K $-74.61K
Q4-2025 $98.12K $-43.23K $33.69M $-33.65M $-50 $-43.23K
Q3-2025 $352.02K $-96.11K $-450K $546.95K $841 $-96.11K
Q2-2025 $424.97K $-201.75K $-450K $646.54K $-5.21K $-201.75K
Q1-2025 $184.66K $-224.01K $30.79M $-30.58M $-20.86K $-224.01K

5-Year Trend Analysis

A comprehensive look at Aimei Health Technology Co., Ltd's financial evolution and strategic trajectory over the past five years.

+ Strengths

The main positives are strategic rather than purely financial. AFJKR has no interest‑bearing debt and a simple corporate structure, making it a clean vehicle for a merger. Through the proposed combination with United Hydrogen, it provides access to an integrated hydrogen platform with operating plants, refueling stations, and a portfolio of patents and innovative projects. United Hydrogen’s end‑to‑end solutions and city‑level operating model give it a differentiated position within the hydrogen ecosystem, with potential to benefit from global decarbonization trends.

! Risks

On a stand‑alone basis, AFJKR’s financials are weak: no revenue, negative operating income, negative operating and free cash flow, severe liquidity constraints, and deeply negative equity. Sustainability depends on external funding and the successful completion of the merger. At the business level, the hydrogen sector is capital‑intensive, policy‑driven, and highly competitive, with uncertain long‑term economics. Regulatory approvals, integration challenges, technology risk, and the need for continuous investment all represent significant uncertainties for the future combined entity.

Outlook

The outlook for AFJKR is highly contingent and binary: in its current form, it is a financially stressed shell with limited standalone prospects; if the merger with United Hydrogen closes and is well executed, it becomes a listed platform for an integrated hydrogen energy business with meaningful growth potential but also considerable risk. The near‑term focus will likely be on securing approvals, closing the transaction, and recapitalizing the balance sheet, while the medium‑term picture will hinge on whether United Hydrogen can convert its innovative projects and infrastructure into stable revenue, positive cash flow, and a durable competitive position in the global hydrogen market.